Non-small-cell lung carcinoma (NSCLC) is any type of epithelial lung cancer other than small cell lung carcinoma (SCLC). NSCLC accounts for about 85% of all lung cancers. As a class, NSCLCs are relatively insensitive to chemotherapy, compared to small cell carcinoma. When possible, they are primarily treated by surgical resection with curative intent, although chemotherapy is increasingly being used both pre-operatively (neoadjuvant chemotherapy) and post-operatively (adjuvant chemotherapy).
We researched this topic for you and found the following best online resources. They are categorized into basic, advanced, and research level based on the extent of information you need. You will be taken to the respective websites by pressing on the links below.
society of nuclear medicine. "fdg pet evaluates immunotherapy for non-small cell lung cancer: molecular imaging is used to monitor a novel immunotherapy that aims to hamper tumors' ability to turn off cancer-fighting immune cells." sciencedaily. sciencedaily, 13 june 2016. www.sciencedaily.com/releases/2016/06/160613165025.htm .
desai c, mehta a, mishra d. usage patterns of biomarkers in non-small-cell lung cancer patients in india: findings from a systematic review and survey. lung india [serial online] 2014 [cited 2016 jul 1];31:249-59. available from: http://www.lungindia.com/text.asp?2014/31/3/249/135767